Cobuzzi Robert Joseph Jr.
Insider CIK 1799838 · DFFN President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRVO CervoMed Inc. | A Award deriv | 2025-02-04 | 2025-02-14 | 27,000 | — | $0 | 27,000 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2024-01-26 | 2024-01-26 | 55,721 | — | $0 | 55,721 | SEC↗ |
| CRVO CervoMed Inc. | A Award deriv | 2023-09-15 | 2023-09-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2023-01-31 | 2023-02-03 | 327 | — | $0 | 0 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2023-01-31 | 2023-02-03 | 121 | — | $0 | 1,616 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2023-01-31 | 2023-02-03 | 327 | — | $0 | 1,737 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-10-31 | 2022-11-02 | 327 | — | $0 | 327 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-10-31 | 2022-11-02 | 121 | — | $0 | 1,410 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-10-31 | 2022-11-02 | 327 | — | $0 | 1,531 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-08-01 | 2022-08-03 | 327 | — | $0 | 654 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-08-01 | 2022-08-03 | 121 | — | $0 | 1,204 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-08-01 | 2022-08-03 | 327 | — | $0 | 1,325 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-05-02 | 2022-05-03 | 327 | — | $0 | 981 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-05-02 | 2022-05-03 | 327 | — | $0 | 1,119 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-05-02 | 2022-05-03 | 121 | — | $0 | 998 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | C Conversion deriv | 2022-04-18 | 2022-04-19 | 100 | $25.00 | $2.5K | 0 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | C Conversion | 2022-04-18 | 2022-04-19 | 100 | $25.00 | $2.5K | 792 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | P Buy deriv | 2022-03-18 | 2022-03-22 | 5,000 | $0.50 | $2.5K | 5,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2022-01-31 | 2022-02-02 | 16,350 | — | $0 | 65,400 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2022-01-31 | 2022-02-02 | 6,049 | — | $0 | 34,602 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2022-01-31 | 2022-02-02 | 16,350 | — | $0 | 40,651 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2022-01-27 | 2022-01-31 | 764,357 | — | $0 | 764,357 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2021-11-01 | 2022-02-02 | 16,350 | — | $0 | 81,750 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2021-11-01 | 2022-02-02 | 16,350 | — | $0 | 30,350 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | D To issuer | 2021-11-01 | 2022-02-02 | 6,049 | — | $0 | 24,301 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise deriv | 2021-11-01 | 2021-11-03 | 16,350 | — | $0 | 81,750 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | M Exercise | 2021-11-01 | 2021-11-03 | 16,350 | — | $0 | 30,350 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2021-03-01 | 2021-03-04 | 161,139 | — | $0 | 161,139 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2021-03-01 | 2021-03-04 | 53,713 | — | $0 | 53,713 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | P Buy | 2020-11-16 | 2020-11-18 | 14,000 | $0.66 | $9.2K | 14,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-09-08 | 2020-09-11 | 475,000 | — | $0 | 475,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-06-17 | 2020-06-18 | 61,300 | — | $0 | 61,300 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-01-07 | 2020-01-13 | 118,600 | — | $0 | 118,600 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2020-01-07 | 2020-01-13 | 98,100 | — | $0 | 98,100 | SEC↗ |